ArticleTherapeutic advances in medical oncology2025

Prolonged response to osimertinib in three patients with refractory metastatic pancreatic adenocarcinomas with

Timothée Vigié et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.